What is a stock summary page? Click here for an overview.
Business Description
Medigen Vaccine Biologics Corp
ISIN : TW0006547003
Description
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of Covid-19 vaccines and Covid-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.65 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 4.53 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 16.1 | |||||
| Beneish M-Score | -2.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.4 | |||||
| 3-Year EBITDA Growth Rate | -68.2 | |||||
| 3-Year FCF Growth Rate | -79.4 | |||||
| 3-Year Book Growth Rate | -7.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.02 | |||||
| 9-Day RSI | 62.19 | |||||
| 14-Day RSI | 57.08 | |||||
| 3-1 Month Momentum % | 11.57 | |||||
| 6-1 Month Momentum % | 23.27 | |||||
| 12-1 Month Momentum % | 4.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.94 | |||||
| Quick Ratio | 9.83 | |||||
| Cash Ratio | 8.94 | |||||
| Days Inventory | 750.19 | |||||
| Days Sales Outstanding | 84.71 | |||||
| Days Payable | 27.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.2 | |||||
| Shareholder Yield % | 9.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.46 | |||||
| Operating Margin % | -24.05 | |||||
| Net Margin % | -13.29 | |||||
| FCF Margin % | 0.95 | |||||
| ROE % | -2.1 | |||||
| ROA % | -1.61 | |||||
| ROIC % | -5.22 | |||||
| 3-Year ROIIC % | 235.86 | |||||
| ROC (Joel Greenblatt) % | -3.43 | |||||
| ROCE % | -1.5 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 39.53 | |||||
| PS Ratio | 27.97 | |||||
| PB Ratio | 4.34 | |||||
| Price-to-Tangible-Book | 4.39 | |||||
| Price-to-Free-Cash-Flow | 1700.01 | |||||
| Price-to-Operating-Cash-Flow | 380.59 | |||||
| EV-to-EBIT | -246.67 | |||||
| EV-to-EBITDA | 202.89 | |||||
| EV-to-Revenue | 25.07 | |||||
| EV-to-FCF | 2010.32 | |||||
| Price-to-GF-Value | 0.84 | |||||
| Price-to-Net-Current-Asset-Value | 8.21 | |||||
| Price-to-Net-Cash | 11.97 | |||||
| Earnings Yield (Greenblatt) % | -0.4 | |||||
| FCF Yield % | 0.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medigen Vaccine Biologics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 605.637 | ||
| EPS (TTM) (NT$) | -0.242 | ||
| Beta | -0.39 | ||
| 3-Year Sharpe Ratio | -0.67 | ||
| 3-Year Sortino Ratio | -0.89 | ||
| Volatility % | 27.3 | ||
| 14-Day RSI | 57.08 | ||
| 14-Day ATR (NT$) | 2.926438 | ||
| 20-Day SMA (NT$) | 48.1675 | ||
| 12-1 Month Momentum % | 4.29 | ||
| 52-Week Range (NT$) | 33.7 - 57 | ||
| Shares Outstanding (Mil) | 328.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medigen Vaccine Biologics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medigen Vaccine Biologics Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medigen Vaccine Biologics Corp Frequently Asked Questions
What is Medigen Vaccine Biologics Corp(ROCO:6547)'s stock price today?
The current price of ROCO:6547 is NT$51.00. The 52 week high of ROCO:6547 is NT$57.00 and 52 week low is NT$33.70.
When is next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547)?
The next earnings date of Medigen Vaccine Biologics Corp(ROCO:6547) is .
Does Medigen Vaccine Biologics Corp(ROCO:6547) pay dividends? If so, how much?
Medigen Vaccine Biologics Corp(ROCO:6547) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers